Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
10/2003
10/16/2003US20030195118 And aryl sulfide derivatives
10/16/2003US20030194375 Anti-epileptogenic agents
10/16/2003CA2513414A1 Pyrimidinedione derivatives useful for the treatment of inflammation and immunological diseases
10/16/2003CA2481825A1 Pyrimidone derivatives useful for the treatment of inflammatin and immunological diseases
10/16/2003CA2481035A1 (2-((2-alkoxy) -phenyl) -cyclopent-1-enyl) aromatic carbo and heterocyclic acid and derivatives
10/16/2003CA2479777A1 6-(4-substituted-anilino)pyrimidine derivatives, method for the preparation thereof and antiviral pharmaceutical composition comprising the same
10/16/2003CA2464144A1 Functionalized compositions for improved immobilization
10/15/2003EP1352650A1 Inhibitors against the production and release of inflammatory cytokines
10/15/2003EP1351959A1 Novel pleuromutilin derivatives
10/15/2003EP1351946A2 Materials and methods to potentiate cancer treatment
10/15/2003EP1351691A1 Substituted 2-aryl-4-arylaminopyrimidines and analogs as activators of caspases and inducers of apoptosis and the use thereof
10/15/2003EP1101760B1 Difluoromethanesulfonyl anilide derivatives, process for the preparation of them and herbicides containing them as the active ingredient
10/15/2003CN1449640A Electroluminescent iridium compounds with fluorinated phenylpyridines, phenylpyrimidines, and phenylquinolines and devices made with such
10/15/2003CN1449390A Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof
10/15/2003CN1449389A Synthesis of chlorinated pyrimidines
10/15/2003CN1449388A Process and intermediates for preparing retroviral protease inhibitors
10/15/2003CN1449380A Phenoxybenzylamine derivatives as selective serotonin re-uptake inhibitors
10/15/2003CN1124269C Substituted pryimidine compounds and their use
10/15/2003CN1124268C Process for preparing aminopyrimidine sulfate by reducing pyrimidine derivative containing nitroso
10/14/2003US6632821 Fungicidal 5-phenyl substituted 2-(cyanoamino) pyrimidines
10/14/2003US6632820 Anticancer agents
10/14/2003US6632817 Use as pesticides such as 2-fluoromethoxyimino-N-methyl-2-((6-aryl-s-triazin-2-yloxy)-phenyl) -acetamide; use on crops as fungicide; microbiocide on wood; chemical synthesis
10/14/2003US6632810 Cyclic diamine compound with condensed-ring groups
10/14/2003US6632495 Pyrimidine-based crosslinking agents
10/14/2003CA2291994C Derivatives and analogues of 2-deoxy-2,3-didehydro-n-acetyl neuraminic acid and their use as antiviral agents
10/14/2003CA2286750C Application and production process of a group of anticancer compounds
10/14/2003CA2184747C Benzamide analogs, useful as parp (adp-ribosyltransferase, adprt) dna repair enzyme inhibitors
10/14/2003CA2122911C 1,3-substituted cycloalkenes and cycloalkanes as central nervous system agents
10/09/2003WO2003082831A1 4-anilino quinazoline derivatives as antiproliferative agents
10/09/2003WO2003082290A1 4-(n-phenylamino)-quinazolines / quinolines as tyrosine kinase inhibitors
10/09/2003WO2003082288A1 Carbamic acid compounds comprising a piperazine linkage as hdac inhibitors
10/09/2003WO2003082280A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
10/09/2003WO2003082263A1 Sulfamic acids as inhibitors of human cytoplasmic protein tyrosine phosphatases
10/09/2003WO2003082239A1 Use of compatible solutes for inhibiting the release of ceramides
10/09/2003WO2003082205A2 Compounds and methods
10/09/2003WO2002024663A3 Pyrimidine compounds and their use
10/09/2003WO2001079189A3 'amides of r-2-(aminoaryl)-propionic acids for use in theprevention of leucocyte activation'
10/09/2003US20030191319 Alpha-and beta-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
10/09/2003US20030191316 A 2-fluorocycloalkyl-2-hydroxy-2-phenyl-ethanoyl)oxy amine salt derivatives; antagonist for treating diseases associated with muscarine M3 receptors, respiratory system disorders; side effect reduction, use as inhalants
10/09/2003US20030191313 Crystalline pharmaceutical
10/09/2003US20030191312 Preparing a C2-substituted purine compound, by reacting a C2-halogenated purine with a boronic acid, a hydroxy or amine compounds; dehydrohalogenation, amination, carboxylation; chemical intermediates
10/09/2003US20030191308 Quinazoline compounds
10/09/2003US20030191279 Of given formula; treatment of hyperproliferative disorders, pancreatitis, kidney disease, vasculogenesis or angiogenesis
10/09/2003US20030191177 Maintenance dosage of beta blocker; cardiovascular disorders
10/09/2003US20030191144 Compounds, compositions and methods for modulating beta-amyloid production
10/09/2003US20030191139 Anticoagulant for mammals
10/09/2003US20030191125 Aryloxy- and arylthiosubstituted pyrimidines and triazines and derivatives thereof
10/09/2003US20030191118 Inhibitors of alpha4 mediated cell adhesion
10/09/2003US20030191074 Antibody therapy; immobilization
10/08/2003EP1349847A1 Oxybenzamides derivatives as factor xa inhibitors
10/08/2003EP1349842A1 1-dimercaptoalkylquinazolin-2,4(1h,3h)-diones as matrix metalloproteinase (mmp) inhibitors
10/08/2003EP1349841A2 Anilinopyrimidine derivatives as ikk inhibitors and compositions and methods related thereto
10/08/2003EP1349840A2 Anilinopyrimidine derivatives as jnk pathway inhibitors and compositions and methods related thereto
10/08/2003EP1105377B1 Pyrimidinone derivatives for the treatment of atherosclerosis
10/08/2003CN1447791A 10-aryl-11-hbenzo [b] fluorene derivatives and analogs for medicinal use
10/08/2003CN1447789A Compounds to treat alzheimer's disease
10/08/2003CN1446806A Amino-sulfonylurea compound with herbicidal activity
10/08/2003CN1123566C Arylsulfonyl hydroxamic acid derivatives
10/07/2003US6630493 Heterocyclically substituted amides, their preparation and use
10/07/2003US6630479 Methods and compositions utilizing quinazolinones
10/07/2003US6630469 5-HT7 receptor antagonists
10/07/2003US6630461 Enyme inhibitors for treating neurodegenerative diseases; inhibition of lipidic peroxidation and nitrogen oxide synthase in warm-blooded animal; for treatment of cardiovascular/brain disorders
10/07/2003CA2270026C Substituted bicyclic derivatives for treating central nervous system disorders
10/07/2003CA2107105C Heterocyclic-cyclic amine derivatives
10/02/2003WO2003080545A2 Substituted phenylacetic acids
10/02/2003WO2003080053A1 Combination treatments for chemokine-mediated diseases
10/02/2003WO2003079986A2 Uracil derivatives as inhibitors of tnf-alpha converting enzyme (tace) and matrix metalloproteinases
10/02/2003WO2003079984A2 Substituted tetracycline compounds
10/02/2003US20030187264 Process for producing carbonyl hydrazones
10/02/2003US20030187263 Viricides
10/02/2003US20030187259 Heterocylic fluoroalkenyl thioethers and the use thereof as pesticides (IV)
10/02/2003US20030187042 Modulate gene expression; antitumor agents; cardiovascular disorders; anticholesterol agents; antilipemic agents
10/02/2003US20030187007 Inhibitors of protein kinase for the treatment of disease
10/02/2003US20030187006 Method for enhancing cognitive function
10/02/2003US20030186995 Substituted bicyclic derivatives useful as anticancer agents
10/02/2003US20030186990 Prodrugs of hiv replication inhibiting pyrimidines
10/02/2003US20030186987 Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
10/02/2003US20030186985 Oxyiminoalkanoic acid derivatives
10/02/2003US20030186984 Substituted cyclohexane derivatives
10/02/2003US20030186967 Anticancer agents; antiinflammatory agents; bone disorders; viricides
10/02/2003US20030186955 Stabilised compositions having and antibacterial activity
10/02/2003CA2479338A1 Substituted phenylacetic acids
10/01/2003EP1348709A2 Thiazolo (4,5-D) pyrimidine compounds
10/01/2003EP0998473B1 Crystal modification of a n-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use
10/01/2003EP0996621B1 TRIAZOLO[4,5-d]PYRIMIDINE DERIVATIVES AS ANTI-THROMBOTIC AGENTS
10/01/2003EP0922037B1 Preparation of fungicidal quinazolinones and useful intermediates
10/01/2003EP0813525B1 Benzamidine derivatives their preparation and their use as anti-coagulants
10/01/2003CN1122665C Herbicidal N-alkenyl heteroaryloxyacetamides
09/2003
09/30/2003US6627755 Quinazolin-4-one AMPA antagonists
09/30/2003US6627628 Cardiovascular diseases such as hypertension, angina pectoris, heart failure, thrombosis and atherosclerosis. The compounds of formula (I) are able to modulate the body's own production of cyclic guanosine monophosphate (cGMP) and are suitable for
09/25/2003WO2003078404A1 Pyrimidine derivatives
09/25/2003WO2003077847A2 Substituted amides
09/25/2003WO2003077828A2 Novel florfenicol-type antibiotics
09/25/2003WO2003077656A1 4-aminopyrimidines and their use for the antimicrobial treatment of surfaces
09/25/2003WO2002060392A3 Use of gal3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
09/25/2003US20030181759 Reacting a benzoic acid with a halogenating agent in presence of palladium catalyst to form halogenated benzoic acid or derivatives
09/25/2003US20030181720 Chemical intermediate for making fungicides; debromination, hydroxylation, formation/c-c/
09/25/2003US20030181635 Process for coupling amino acids to an antifolate scaffold
09/25/2003US20030181474 2,4-Di(hetero-)arylamino(-oxy)-5-substituted pyrimidines as antineoplastic agents
09/25/2003US20030181465 Pyrimidines as novel openers of potassium ion channels
1 ... 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 ... 427